Company Overview
IMMUNOVANT, INC.
IMVTRevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
—M
2024 FY
Net Income
-414M
2024 FY
Shares Outstanding
152M
2024 FY
EPS
-2.73USD
2024 FY
Company Information
SIC Code
2836
CIK Code
1764013
Exchange
Nasdaq
Location
US